Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Western Uranium & Vanadium (WSTRF) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Western Uranium & Vanadium (WSTRF) over the last 8 years, with Q3 2025 value amounting to $3.2 million.

  • Western Uranium & Vanadium's Cash & Equivalents fell 5197.57% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year decrease of 5197.57%. This contributed to the annual value of $5.5 million for FY2024, which is 4051.99% down from last year.
  • According to the latest figures from Q3 2025, Western Uranium & Vanadium's Cash & Equivalents is $3.2 million, which was down 5197.57% from $4.4 million recorded in Q2 2025.
  • Over the past 5 years, Western Uranium & Vanadium's Cash & Equivalents peaked at $11.5 million during Q1 2024, and registered a low of $880821.0 during Q4 2021.
  • For the 5-year period, Western Uranium & Vanadium's Cash & Equivalents averaged around $6.4 million, with its median value being $5.8 million (2023).
  • As far as peak fluctuations go, Western Uranium & Vanadium's Cash & Equivalents skyrocketed by 99921.69% in 2022, and later tumbled by 7594.86% in 2025.
  • Over the past 5 years, Western Uranium & Vanadium's Cash & Equivalents (Quarter) stood at $880821.0 in 2021, then surged by 999.22% to $9.7 million in 2022, then decreased by 4.8% to $9.2 million in 2023, then crashed by 40.52% to $5.5 million in 2024, then tumbled by 41.78% to $3.2 million in 2025.
  • Its Cash & Equivalents was $3.2 million in Q3 2025, compared to $4.4 million in Q2 2025 and $2.8 million in Q1 2025.